Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Role of the microRNA-7 (miR-7) in the Inhibition of Chemoresistance and Migration of Lymphoma Non-Hodgkin's through Regulation of YY1 and KLF4

Mario Morales-Martinez, PhDSt, Gabriel G Vega, PhD, Natividad Neri Munoz, PhD MD, M. J Nambo, Isabel Alvarado, Ivonne Cuadra, MD, M. A. Duran-Padilla, MD, Sara Huerta-Yepez, PhD, Mario I Vega, PhD

Blood (2019) 134 (Supplement_1): 5220.

https://doi.org/10.1182/blood-2019-121469

Published: 2019

Journal Articles

YY1 Controls Hematopoietic Stem Cell Quiescence By Repressing Cohesin Expression

Zhanping Lu, PhD, Anna L F. V. Assumpção, Aaron D Viny, MDMS, Ross L. Levine, MD, Xuan Pan, PhD DVM

Blood (2018) 132 (Supplement 1): 3831.

https://doi.org/10.1182/blood-2018-99-118679

Published: 2018

Journal Articles

Molecular Determinants for Polycomb Group Protein YY1 Control of Hematopoietic Stem Cell Quiescence

Zhanping Lu, PhD, Courtney Hong, Guangyao Kong, PhD, Anna L F. V. Assumpção, Irene Ong, Emery H Bresnick, PhD, Jing Zhang, PhD, Xuan Pan, PhD DVM

Blood (2017) 130 (Supplement 1): 1140.

https://doi.org/10.1182/blood.V130.Suppl_1.1140.1140

Published: 2017

Journal Articles

Analysis of Mir-7 (microRNA-7) Expression in Non-Hodgkin Lymphomas and Its Possible Role in the Regulation of the Transcription Factor KLF4 and YY1

Mario Morales-Martinez, PhDSt, Gabriel G Vega, PhD, Leticia Rocha-Zavaleta, Natividad Neri Munoz, PhD MD, M. J Nambo, Isabel Alvarado, Ivonne Cuadra, MD, Otoniel Martinez-Maza, PhD, Sara Huerta-Yepez, PhD, Mario Vega, PhD

Blood (2017) 130 (Supplement 1): 5143.

https://doi.org/10.1182/blood.V130.Suppl_1.5143.5143

Published: 2017

Journal Articles

Yin Yang 1 (YY1) Acting Primarily As an Oncogene and Rarely As a Tumor Suppressor in Distinct Hematological Malignancies: Prognostic and Therapeutic Implications

Samantha Kaufhold, Stephanie Wottrich, Hermes Garban, MD PhD, Massimo Libra, MD Ph.D., Benjamin Bonavida, PhD

Blood (2016) 128 (22): 5122.

https://doi.org/10.1182/blood.V128.22.5122.5122

Published: 2016

Journal Articles

In silico Tissue-Based Expression Analysis of YY1 and Cancer Stem Cell (CSC) Transcription Factors in Hematological Malignancies: Unraveling New Therapeutic Targets

Samantha Kaufhold, Hermes Garban, MD PhD, Benjamin Bonavida, PhD

Blood (2015) 126 (23): 4814.

https://doi.org/10.1182/blood.V126.23.4814.4814

Published: 2015

Journal Articles

KLF4 and YY1 Are Resistant Factors in NHL and Potential Therapeutic Targets: The New Resistant NF-κb/YY1/KLF4/Bcl xL /Mcl-1 Axis

Mayra R Montecillo-Aguado, MsC, Gabriel G Vega, PhDstudent, Hector Mayani, PhD, Sara Huerta-Yepez, PhD, Benjamin Bonavida, PhD, Otoniel Martinez-Maza, PhD, Mario I. Vega, PhD

Blood (2015) 126 (23): 1466.

https://doi.org/10.1182/blood.V126.23.1466.1466

Published: 2015

Journal Articles

Yin Yang 1 (YY1) Regulates The Transcription Of The Gene Krüppel-Like Factor 4 ( KLF4 ) In Pediatric Burkitt Lymphoma: Clinical Implications

Mario I Vega, PhD, Alberto Valencia-Hipolito, MD/PhD, Miriam Hernandez-Atenogenes, ChB, Gabriel G Vega, MDVZ/PhD, Hector Mayani, PhD, Sara Huerta-Yepez, PhD, Benjamin Bonavida, Ph.D, Otoniel Martinez-Maza, PhD

Blood (2013) 122 (21): 3004.

https://doi.org/10.1182/blood.V122.21.3004.3004

Published: 2013

Journal Articles

Targeting the Over-Expressed Transcription Factor Yin-Yang 1 (YY1) Sensitizes Resistant Multiple Myeloma (MM) Cell Lines to Apoptosis by Bortezomib or Melphalan,

Hong Liu, Sara Huerta-Yepez, Ph.D, Clara M. Rivera-Pazos, MD, Ma de Lourdes Cabera-Muñoz, MD, Stavroula Baritaki, Ph.D, Suzie Vardanyan, Manuel L Penichet, M.D., Ph.D., Haiming Chen, James R. Berenson, MD, Benjamin Bonavida, Ph.D

Blood (2011) 118 (21): 3991.

https://doi.org/10.1182/blood.V118.21.3991.3991

Published: 2011

Journal Articles

Co-Overexpression of YY1 and Gp-170 (MDR1) in Childhood Acute Lymphocytic Leukemia (ALL): Transcription Regulation of Gp-170 by YY1 and Prognostic Significance,

Gabriela andres-Antonio, Jesus Rangel-Santiago, B.S., Ana B Tirado-Rodriguez, B.S., Elisa Dorantes-Acosta, MD MSc, Mario I Vega, PhD, Guillermo Aquino-Jarquin, PhD, Briseida Lopez, MD, Elba Jimenez, MD, Rosana Pelayo, PhD, Benjamin Bonavida, Ph.D, Aurora Medina-Sanson, MD, Sara Huerta-Yepez, PhD

Blood (2011) 118 (21): 3567.

https://doi.org/10.1182/blood.V118.21.3567.3567

Published: 2011

Journal Articles

Rituximab Inhibits the PI3K/Akt Survival Pathway In B-NHL Cells Via Induction of the PTEN Tumor Suppressor: Pivotal Roles of the Inhibition of the PTEN Repressors Snail and YY1

Stavroula Baritaki, PhD, Eriko Suzuki, Ph.D, Mario I. Vega, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD

Blood (2010) 116 (21): 3152.

https://doi.org/10.1182/blood.V116.21.3152.3152

Published: 2010

Journal Articles

An ADCC-Independent Mechanism of Rituximab-Mediated B-NHL Cells Depletion Via Sensitization to Cell Death through the Expression of TRAIL on NK Cells

Mario I. Vega, PhD, Sara Huerta-Yepez, PhD, Melisa Martinez-Paniagua, BSc, MSc, Stavroula Baritaki, PhD, Benjamin Bonavida, PhD

Blood (2010) 116 (21): 4919.

https://doi.org/10.1182/blood.V116.21.4919.4919

Published: 2010

Journal Articles

Reversal of Drug/TRAIL-Resistant B-NHL Cells to Apoptosis by the Combination of Rituximab (anti-CD20) and Either Mapatumumab or Lexatumumab

Mario I. Vega, PhD, Sara Huerta-Yepez, PhD, Melisa Martinez-Paniagua, BSc, MSc, Stavroula Baritaki, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD

Blood (2010) 116 (21): 4931.

https://doi.org/10.1182/blood.V116.21.4931.4931

Published: 2010

Journal Articles

Photodynamic Therapy (PDT)-Mediated Inhibition of the Transcription Factor Yin Yang 1 (YY1) That Regulates Resistance In Lymphoma

Valentina Rapozzi, Ph.D, Sara Huerta-Yepez, PhD, Abhijeet Joshi, Mario I. Vega, PhD, Stavroula Baritaki, PhD, Luigi E. Xodo, Ph.D, Benjamin Bonavida, PhD

Blood (2010) 116 (21): 5113.

https://doi.org/10.1182/blood.V116.21.5113.5113

Published: 2010

Journal Articles

The Pivotal Role of Yin Yang 1 (YY1) Inhibition (and downstream Bcl-2/Bcl xl ) by Galiximab (anti-CD80 mAb) In the Reversal of Resistance of B-NHL Cells to Chemotherapy

Melisa Martinez-Paniagua, BSc, MSc, Mario I. Vega, PhD, Sara Huerta-Yepez, PhD, Hari Hariharan, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD

Blood (2010) 116 (21): 2887.

https://doi.org/10.1182/blood.V116.21.2887.2887

Published: 2010

Journal Articles

Inverse Relationship Between the Transcription Repressor Yin Yang 1 (YY1) and the TRAIL Death Receptor DR5 in AIDS-Related Non-Hodgkin's Lymphoma Tissues: Potential Prognostic Biomarkers and Targets for Therapeutic Intervention.

Sara Huerta-Yepez, PhD., Mario I. Vega, PhD, Clara Rivera-Pazos, MD, Otoniel Martinez-Maza, Ph.D., James R. Berenson, MD, Benjamin Bonavida, PhD

Blood (2009) 114 (22): 1932.

https://doi.org/10.1182/blood.V114.22.1932.1932

Published: 2009

Journal Articles

High Expression of Transcription Factor Yin Yang 1 and Multidrug Resistance Protein in Early B-Cell Precursors in Childhood Acute Lymphoblastic Leukemia.

Gabriela Antonio-Andres, MSc, Rosana Pelayo, PhD, Elisa Dorantes-Acosta, MD, Briseida Lopez-Martinez, MD, Belen Tirado-Rodriguez, BsC, Guadalupe Diaz-Elizondo, B.Sc., Mario I. Vega, PhD, Lourdes Arriaga-Pizano, PhD, Guillermina Juliana Baay-Guzmán, B.Sc., Daniel Hernandez-Cueto, Tech, Benjamin Bonavida, PhD, Aurora Medina-Sanson, MD, Sara Huerta-Yepez, PhD.

Blood (2009) 114 (22): 4695.

https://doi.org/10.1182/blood.V114.22.4695.4695

Published: 2009

Journal Articles

Prognostic Significance of Both the Cytoplasmic and Nuclear Overexpression of Yin-Yang 1 (YY1) among Patients with Multiple Myeloma (MM)

Sara Huerta-Yepez, Ph.D., Clara Rivera-Pazos, MD, Massimo Libra, Stavroula Baritaki, Haiming Chen, MD, PhD, James R. Berenson, MD, Benjamin Bonavida, PhD

Blood (2008) 112 (11): 2730.

https://doi.org/10.1182/blood.V112.11.2730.2730

Published: 2008

Journal Articles

Galiximab (anti-CD80 mAb)-Induced Cell Triggering Results in the Inhibition of Constitutive NF-Kb Activity in Raji: Contrasting Roles of Snail and RKIP in the Regulation of Drug/Immune Resistance

Melisa Martinez-Paniagua, Mario I. Vega, PhD, Sara Huerta-Yepez, PhD., Stavroula Baritaki, James R. Berenson, MD, Haris Hariharan, Benjamin Bonavida, PhD

Blood (2008) 112 (11): 3623.

https://doi.org/10.1182/blood.V112.11.3623.3623

Published: 2008

Journal Articles

Molecular Mechanism by Which Rituximab Sensitizes B-NHL Cells to TRAIL Apoptosis: Induction of RKIP and DR5 Expression Via Inhibition of NF-Kb, Snail, and YY1.

Mario I. Vega, PhD, Melisa Martinez-Paniagua, Sara Huerta-Yepez, PhD., Yeung Kam, Stavroula Baritaki, Benjamin Bonavida, PhD

Blood (2008) 112 (11): 1596.

https://doi.org/10.1182/blood.V112.11.1596.1596

Published: 2008

NARROW

Role of the microRNA-7 (miR-7) in the Inhibition of Chemoresistance and Migration of Lymphoma Non-Hodgkin's through Regulation of YY1 and KLF4

YY1 Controls Hematopoietic Stem Cell Quiescence By Repressing Cohesin Expression

Molecular Determinants for Polycomb Group Protein YY1 Control of Hematopoietic Stem Cell Quiescence

Analysis of Mir-7 (microRNA-7) Expression in Non-Hodgkin Lymphomas and Its Possible Role in the Regulation of the Transcription Factor KLF4 and YY1

Yin Yang 1 (YY1) Acting Primarily As an Oncogene and Rarely As a Tumor Suppressor in Distinct Hematological Malignancies: Prognostic and Therapeutic Implications

In silico Tissue-Based Expression Analysis of YY1 and Cancer Stem Cell (CSC) Transcription Factors in Hematological Malignancies: Unraveling New Therapeutic Targets

KLF4 and YY1 Are Resistant Factors in NHL and Potential Therapeutic Targets: The New Resistant NF-κb/YY1/KLF4/Bcl xL /Mcl-1 Axis

Yin Yang 1 (YY1) Regulates The Transcription Of The Gene Krüppel-Like Factor 4 ( KLF4 ) In Pediatric Burkitt Lymphoma: Clinical Implications

Targeting the Over-Expressed Transcription Factor Yin-Yang 1 (YY1) Sensitizes Resistant Multiple Myeloma (MM) Cell Lines to Apoptosis by Bortezomib or Melphalan,

Co-Overexpression of YY1 and Gp-170 (MDR1) in Childhood Acute Lymphocytic Leukemia (ALL): Transcription Regulation of Gp-170 by YY1 and Prognostic Significance,

Rituximab Inhibits the PI3K/Akt Survival Pathway In B-NHL Cells Via Induction of the PTEN Tumor Suppressor: Pivotal Roles of the Inhibition of the PTEN Repressors Snail and YY1

An ADCC-Independent Mechanism of Rituximab-Mediated B-NHL Cells Depletion Via Sensitization to Cell Death through the Expression of TRAIL on NK Cells

Reversal of Drug/TRAIL-Resistant B-NHL Cells to Apoptosis by the Combination of Rituximab (anti-CD20) and Either Mapatumumab or Lexatumumab

Photodynamic Therapy (PDT)-Mediated Inhibition of the Transcription Factor Yin Yang 1 (YY1) That Regulates Resistance In Lymphoma

The Pivotal Role of Yin Yang 1 (YY1) Inhibition (and downstream Bcl-2/Bcl xl ) by Galiximab (anti-CD80 mAb) In the Reversal of Resistance of B-NHL Cells to Chemotherapy

Inverse Relationship Between the Transcription Repressor Yin Yang 1 (YY1) and the TRAIL Death Receptor DR5 in AIDS-Related Non-Hodgkin's Lymphoma Tissues: Potential Prognostic Biomarkers and Targets for Therapeutic Intervention.

High Expression of Transcription Factor Yin Yang 1 and Multidrug Resistance Protein in Early B-Cell Precursors in Childhood Acute Lymphoblastic Leukemia.

Prognostic Significance of Both the Cytoplasmic and Nuclear Overexpression of Yin-Yang 1 (YY1) among Patients with Multiple Myeloma (MM)

Galiximab (anti-CD80 mAb)-Induced Cell Triggering Results in the Inhibition of Constitutive NF-Kb Activity in Raji: Contrasting Roles of Snail and RKIP in the Regulation of Drug/Immune Resistance

Molecular Mechanism by Which Rituximab Sensitizes B-NHL Cells to TRAIL Apoptosis: Induction of RKIP and DR5 Expression Via Inhibition of NF-Kb, Snail, and YY1.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only